Jean-Marc Rolain
Jean-Marc Rolain
MEPHI, IHU Méditerranée Infection, Aix-Marseille University
Verified email at - Homepage
Cited by
Cited by
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
P Gautret, JC Lagier, P Parola, L Meddeb, M Mailhe, B Doudier, J Courjon, ...
International journal of antimicrobial agents 56 (1), 105949, 2020
Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry
P Seng, M Drancourt, F Gouriet, B La Scola, PE Fournier, JM Rolain, ...
Clinical infectious diseases 49 (4), 543-551, 2009
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
AO Olaitan, S Morand, JM Rolain
Frontiers in microbiology 5, 643, 2014
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
CA Devaux, JM Rolain, P Colson, D Raoult
International journal of antimicrobial agents 55 (5), 105938, 2020
The global threat of antimicrobial resistance: science for intervention
I Roca, M Akova, F Baquero, J Carlet, M Cavaleri, S Coenen, J Cohen, ...
New microbes and new infections 6, 22-29, 2015
ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes
SK Gupta, BR Padmanabhan, SM Diene, R Lopez-Rojas, M Kempf, ...
Antimicrobial agents and chemotherapy 58 (1), 212-220, 2014
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
P Colson, JM Rolain, JC Lagier, P Brouqui, D Raoult
International journal of antimicrobial agents 55 (4), 105932, 2020
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
P Gautret, JC Lagier, P Parola, L Meddeb, J Sevestre, M Mailhe, ...
Travel medicine and infectious disease 34, 101663, 2020
Culture of previously uncultured members of the human gut microbiota by culturomics
JC Lagier, S Khelaifia, MT Alou, S Ndongo, N Dione, P Hugon, A Caputo, ...
Nature microbiology 1 (12), 2016
Culturing the human microbiota and culturomics
JC Lagier, G Dubourg, M Million, F Cadoret, M Bilen, F Fenollar, ...
Nature Reviews Microbiology 16 (9), 540-550, 2018
Colistin: an update on the antibiotic of the 21st century
S Biswas, JM Brunel, JC Dubus, M Reynaud-Gaubert, JM Rolain
Expert review of anti-infective therapy 10 (8), 917-934, 2012
Recommendations for Treatment of Human Infections Caused by Bartonella Species
JM Rolain, P Brouqui, JE Koehler, C Maguina, MJ Dolan, D Raoult
Antimicrobial agents and chemotherapy 48 (6), 1921-1933, 2004
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France
M Million, JC Lagier, P Gautret, P Colson, PE Fournier, S Amrane, ...
Travel medicine and infectious disease 35, 101738, 2020
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
P Colson, JM Rolain, D Raoult
International journal of antimicrobial agents 55 (3), 105923, 2020
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
CA Devaux, JM Rolain, D Raoult
Journal of Microbiology, Immunology and Infection 53 (3), 425-435, 2020
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options
M Kempf, JM Rolain
International journal of antimicrobial agents 39 (2), 105-114, 2012
The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee
MJ Ellington, O Ekelund, FM Aarestrup, R Canton, M Doumith, C Giske, ...
Clinical microbiology and infection 23 (1), 2-22, 2017
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
JM Rolain, P Colson, D Raoult
International journal of antimicrobial agents 30 (4), 297-308, 2007
Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections
A Sakr, F Brégeon, JL Mège, JM Rolain, O Blin
Frontiers in microbiology 9, 2419, 2018
Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of matrix-assisted laser desorption ionization–time of flight mass spectrometry
P Seng, C Abat, JM Rolain, P Colson, JC Lagier, F Gouriet, PE Fournier, ...
Journal of clinical microbiology 51 (7), 2182-2194, 2013
The system can't perform the operation now. Try again later.
Articles 1–20